Overview
Michael Bar is a Hematologist Oncology specialist and a Hematologist in Stamford, Connecticut. Dr. Bar is rated as an Advanced provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, and Small Lymphocytic Lymphoma (SLL).
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Weill Medical College Of Cornell
John Allan is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Allan has been practicing medicine for over 16 years and is rated as an Elite provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Splenectomy.
Weill Medical College Of Cornell
Richard Furman is a Hematologist and an Oncologist in New York, New York. Dr. Furman is rated as an Elite provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Lymphadenectomy.
Icahn School Of Medicine At Mount Sinai
Adam Kittai is a Hematologist and a Hematologist Oncology provider in New York, New York. Dr. Kittai is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Small Lymphocytic Lymphoma (SLL), and Bone Marrow Aspiration. Dr. Kittai is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Myelogenous Leukemia (CML)Dr. Bar isDistinguished. Learn about Chronic Myelogenous Leukemia (CML).
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Bar isDistinguished. Learn about Multiple Myeloma.
- Non-Hodgkin LymphomaDr. Bar isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Schnitzler SyndromeDr. Bar isDistinguished. Learn about Schnitzler Syndrome.
- Advanced
- Acute Eosinophilic Pneumonia
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)
- Adult Immune Thrombocytopenia
- Antiphospholipid SyndromeDr. Bar isAdvanced. Learn about Antiphospholipid Syndrome.
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Mountain SicknessDr. Bar isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Promyelocytic LeukemiaDr. Bar isExperienced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Bar isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer